Your browser doesn't support javascript.
loading
Temperature regulates Rab3a and mast cell-derived exosomal FcεRI to inhibit mast cell activation.
Liao, Wenjing; Chen, Gui; Song, Lijuan; Xu, Meiqian; Li, Hao; Wang, Yiyan; Wang, Xiaofen; Ye, Jinfeng; Ren, Mei; Kuang, Xiaoxuan; Tang, Yaqiang; Yang, Saixuan; Ning, Xiaoping; Xie, Jianlei; Yang, Zhaowei; Zhang, Xiaowen.
Afiliación
  • Liao W; The State Key Laboratory of Respiratory Disease, Department of Otolaryngology, Head and Neck Surgery, Laboratory of ENT-HNS Disease, Guangzhou Institute of Respiratory Health, First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
  • Chen G; Innovation and Transformation Platform of Upper Airway Disease in Guangdong Province, Guangzhou, China.
  • Song L; The State Key Laboratory of Respiratory Disease, Department of Otolaryngology, Head and Neck Surgery, Laboratory of ENT-HNS Disease, Guangzhou Institute of Respiratory Health, First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
  • Xu M; Innovation and Transformation Platform of Upper Airway Disease in Guangdong Province, Guangzhou, China.
  • Li H; The State Key Laboratory of Respiratory Disease, Department of Otolaryngology, Head and Neck Surgery, Laboratory of ENT-HNS Disease, Guangzhou Institute of Respiratory Health, First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
  • Wang Y; Innovation and Transformation Platform of Upper Airway Disease in Guangdong Province, Guangzhou, China.
  • Wang X; The State Key Laboratory of Respiratory Disease, Department of Otolaryngology, Head and Neck Surgery, Laboratory of ENT-HNS Disease, Guangzhou Institute of Respiratory Health, First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
  • Ye J; Innovation and Transformation Platform of Upper Airway Disease in Guangdong Province, Guangzhou, China.
  • Ren M; The State Key Laboratory of Respiratory Disease, Department of Otolaryngology, Head and Neck Surgery, Laboratory of ENT-HNS Disease, Guangzhou Institute of Respiratory Health, First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
  • Kuang X; Innovation and Transformation Platform of Upper Airway Disease in Guangdong Province, Guangzhou, China.
  • Tang Y; The State Key Laboratory of Respiratory Disease, Department of Otolaryngology, Head and Neck Surgery, Laboratory of ENT-HNS Disease, Guangzhou Institute of Respiratory Health, First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
  • Yang S; Innovation and Transformation Platform of Upper Airway Disease in Guangdong Province, Guangzhou, China.
  • Ning X; The State Key Laboratory of Respiratory Disease, Department of Otolaryngology, Head and Neck Surgery, Laboratory of ENT-HNS Disease, Guangzhou Institute of Respiratory Health, First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
  • Xie J; Innovation and Transformation Platform of Upper Airway Disease in Guangdong Province, Guangzhou, China.
  • Yang Z; The State Key Laboratory of Respiratory Disease, Department of Otolaryngology, Head and Neck Surgery, Laboratory of ENT-HNS Disease, Guangzhou Institute of Respiratory Health, First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
  • Zhang X; Innovation and Transformation Platform of Upper Airway Disease in Guangdong Province, Guangzhou, China.
Allergy ; 78(6): 1707-1710, 2023 06.
Article en En | MEDLINE | ID: mdl-37069491

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Receptores de IgE / Mastocitos Límite: Humans Idioma: En Revista: Allergy Año: 2023 Tipo del documento: Article País de afiliación: China Pais de publicación: Dinamarca

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Receptores de IgE / Mastocitos Límite: Humans Idioma: En Revista: Allergy Año: 2023 Tipo del documento: Article País de afiliación: China Pais de publicación: Dinamarca